Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism

FEBS Letters

Volumn 580, Issue 7, 2006, Pages 1733-1739

  Fogli, Stefano ^a   Nieri, Paola ^a   Chicca, Andrea ^a   Adinolfi, Barbara ^a   Mariotti, Veronica ^a   Iacopetti, Paola ^a   Breschi, Maria Cristina ^a   Pellegrini, Silvia ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Apoptosis; Cannabinoids; Microarray; Pancreatic cancer; Synergism

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ARACHIDONYL 2' CHLOROETHYLAMIDE; CANNABINOID DERIVATIVE; FLUOROURACIL; JANUS KINASE; RIMONABANT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DEATH; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MICROARRAY ANALYSIS; PANCREAS CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CANNABINOIDS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; INHIBITORY CONCENTRATION 50; PANCREATIC NEOPLASMS; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID;

AGOUTI PACA;

EID: 33644901536     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.02.024     Document Type: Article

References (19)

1. W. Hall, M. Christie, and D. Currow Cannabinoids and cancer: causation, remediation, and palliation Lancet Oncol. 6 2005 35 42
2. M. Guzman, C. Sanchez, and I. Galve-Roperh Control of the cell survival/death decision by cannabinoids J. Mol. Med. 78 2001 613 625
3. S. Sarfaraz, F. Afaq, V.M. Adhami, and H. Mukhtar Cannabinoid receptor as a novel target for the treatment of prostate cancer Cancer Res. 65 2005 1635 1641
4. A. Vaccani, P. Massi, A. Colombo, T. Rubino, and D. Parolaro Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism Br. J. Pharmacol. 144 2005 1032 1036
5. T. Powles, R. te Poele, J. Shamash, T. Chaplin, D. Propper, S. Joel, T. Oliver, and W.M. Liu Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway Blood 105 2005 1214 1221
6. L. Ruiz, A. Miguel, and I. Diaz-Laviada Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism FEBS Lett. 458 1999 400 404
7. C. Blazquez, M.L. Casanova, A. Planas, T.G. Del Pulgar, C. Villanueva, M.J. Fernandez-Acenero, J. Aragones, J.W. Huffman, J.L. Jorcano, and M. Guzman Inhibition of tumor angiogenesis by cannabinoids FASEB J. 17 2003 529 531
8. M.L. Casanova, C. Blazquez, J. Martinez-Palacio, C. Villanueva, M.J. Fernandez-Acenero, J.W. Huffman, J.L. Jorcano, and M. Guzman Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors J. Clin. Invest. 111 2003 43 50
9. S. Hart, O.M. Fischer, and A. Ullrich Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor Cancer Res. 64 2004 1943 1950
10. R.J. McKallip, C. Lombard, M. Fisher, B.R. Martin, S. Ryu, S. Grant, P.S. Nagarkatti, and M. Nagarkatti Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease Blood 100 2002 627 634
11. T.C. Chou, Q.H. Tan, and F.M. Sirotnak Quantitation of the synergistic interaction of edatrexate and cisplatin in vitro Cancer Chemother. Pharmacol. 31 1993 259 264
12. L. Yang, Z. Cao, H. Yan, and W.C. Wood Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy Cancer Res. 63 2003 6815 6824
13. G.D. Basu, L.B. Pathangey, T.L. Tinder, S.J. Gendler, and P. Mukherjee Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells Breast Cancer Res. 7 2005 R422 R435
14. M.T. Yip-Schneider, D.S. Barnard, S.D. Billings, L. Cheng, D.K. Heilman, A. Lin, S.J. Marshall, P.L. Crowell, M.S. Marshall, and C.J. Sweeney Cyclooxygenase-2 expression in human pancreatic adenocarcinomas Carcinogenesis 21 2000 139 146
15. H. Ding, C. Han, J. Zhu, C.S. Chen, and S.M. D'Ambrosio Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9 Int. J. Cancer 113 2005 803 810
16. L. Bröker, F.A.E. Kruyt, and G. Giaccone Cell death independent of caspases: a review Clin. Cancer Res. 11 2005 3155 3162
17. J. Subhashini, S.V. Mahipal, and P. Reddanna Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro Cancer Lett. 224 2005 31 43
18. C.G. Willett, B.G. Czito, J.C. Bendell, and D.P. Ryan Locally advanced pancreatic cancer J. Clin. Oncol. 23 2005 4538 4544
19. M. Milella, A. Gelibter, S. Di Cosimo, E. Bria, E.M. Ruggeri, P. Carlini, P. Malaguti, M. Pellicciotta, E. Terzoli, and F. Cognetti Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma Cancer 101 2004 133 138